查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571602

美国雇主和工作场所药物测试市场规模、份额、趋势分析报告：按类型、按产品、按模式、按药物、按最终用途、按地区、细分市场预测，2024-2030 年

U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens), By Product, By Mode, By Drug, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国雇主和工作场所药物测试市场的成长和趋势：

Grand View Research, Inc.最新报告显示，预计2030年美国雇主和工作场所药物检测市场规模将达到34.7亿美元，2024年至2030年复合年增长率为5.1%。

监管合规性是市场成长的关键驱动力。运输部(DOT) 和药物滥用和心理健康服务管理局 (SAMHSA) 等联邦法规要求对安全敏感工作进行测试，以确保职场安全并降低责任风险。这些法规要求对各个行业进行检查，特别是那些涉及重型机械和运输的行业。

2020年，美国公共卫生协会倡导采取综合策略来解决阿片类药物使用障碍（OUD）和职业环境中的过量摄取风险，进一步强调了药物检测的重要性。建议包括加强伤害预防计划、解决人体工学风险、提供阿片类药物滥用教育、提供同侪支持以及透过劳工赔偿来规范阿片类药物处方。这项政策推动凸显了对积极药物检测措施日益增长的需求。

为了应对这些监管和政策压力，美国运输部将于 2023 年 5 月敲定新法规，要求运输部规定的药物检测涉及至少两个 SAMHSA 认可的检测实验室，并决定允许进行口腔液检测。这一发展凸显了药物测试的发展，并提高了测试程序的灵活性和准确性。透过扩大检测选择，新法规预计将推动对口腔液检测解决方案的需求，使雇主和检测提供者都受益，并支持整体市场成长。

此外，劳动力中物质使用障碍（SUD）的增加正在显着影响美国雇主/职场药物测试市场的成长。这些疾病的普遍存在会导致缺勤率升高、生产力降低以及工作场所事故增加。这迫使雇主实施严格的药物检测计划，以快速识别和解决药物滥用问题。这种积极主动的方法不仅有助于维持安全和高效的职场环境，还可以减少与残疾员工相关的业务风险和法律责任。人们对 SUD 负面影响的认识不断提高，推动了对更先进、更全面的药物检测解决方案的需求，从而促进了市场扩张。

此外，随着组织优先考虑创造更安全的职场环境，药物测试已成为安全计画的重要组成部分。对与药物滥用相关的风险（包括判断力受损和事故率增加）的认识正在促使雇主实施强有力的政策。这种对安全的重视在建设业、製造和运输等高风险行业尤其明显。透过识别和解决药物滥用问题，雇主可以减少潜在危险，提高职场的整体安全性，并降低相关成本。对安全的认识和承诺的提高增加了对综合解决方案的需求并推动了市场成长。

美国雇主和工作场所药物检测市场报告亮点

  • 按类型划分，离职后细分市场将在 2023 年以 80.80% 的销售份额占据市场主导地位。减少事故、工伤和相关责任的风险是美国离职后药物检测的关键驱动力。建筑、运输和製造等高风险行业的雇主敏锐地意识到残疾员工对职场安全的危险。
  • 以产品来看，消耗品细分市场占据主导地位，2023 年销售份额为 33.42%。这部分对于确保药物测试的准确性和可靠性至关重要，并直接影响药物筛检计划的有效性。监管环境极大地影响了消费品领域，运输部(DOT) 和药物滥用和心理健康服务管理局 (SAMHSA) 的联邦指导方针为药物测试程序和相关产品製定了具体标准。
  • 从模式来看，尿液细分市场占最大市场占有率，2023年将达41.38%。由于尿液检查的可靠性和易用性，它是雇主最常用的僱用前药物测试类型。这种方法仍然是受监管和不受监管行业的主要方法，确保在各个领域的一致应用。
  • 按药品划分，大麻/大麻细分市场在 2023 年占据最大市场占有率，达到 56.89%，预计在预测期内将以最快的复合年增长率增长。许多州的大麻合法化和非刑事化减少了大麻使用的耻辱，导致消费增加，包括僱员的消费。
  • 依最终用途划分，其他专业服务细分市场占据主导地位，2023 年销售份额最大，为 39.11%。美国雇主和工作场所药物检测的需求正在受到各种专业服务部门的推动，包括专业、技术、批发贸易和政府。
  • 儿科心臟肿瘤诊断市场的竞争非常激烈。主要企业采取各种策略，包括新产品开发、联盟、收购和合併，以满足客户未满足的需求。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国雇主和工作场所药物检测市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望。
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国雇主和工作场所药物测试市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19 影响分析

第四章美国雇主和工作场所药物检测市场：类型估计和趋势分析

  • 细分仪表板
  • 美国雇主和工作场所药物检测市场类型变化分析
  • 2018-2030 年美国雇主及工作场所药物检测市场规模及趋势分析（按类型）
  • 就业前药物测试
  • 就业后

第五章美国雇主与工作场所药物检测市场：产品评估与趋势分析

  • 细分仪表板
  • 美国雇主与工作场所药物检测市场产品变化分析
  • 2018-2030 年美国雇主及工作场所药物检测市场规模及趋势分析（依产品）
  • 消耗品
  • 装置
  • 快速检测装置
  • 服务

第六章美国雇主和工作场所药物检测市场：模式估计和趋势分析

  • 细分仪表板
  • 美国雇主与工作场所药物检测市场模式变化分析
  • 2018-2030 年美国雇主及工作场所药物检测市场规模及趋势分析（按模式）
  • 尿
  • 头髮
  • 唾液
  • 即时测试

第七章美国雇主和工作场所药物检测市场：药物估计和趋势分析

  • 细分仪表板
  • 美国雇主与工作场所药物检测市场药物波动分析
  • 2018-2030 年美国雇主及职场药物检测市场规模及趋势分析（依药物）
  • 酒精
  • 大麻/大麻
  • 古柯碱
  • 阿片类药物
  • 安非他命和甲基安非他命
  • LSD
  • 其他的

第八章美国雇主和工作场所药物测试市场：最终用途估计和趋势分析

  • 细分仪表板
  • 美国雇主和工作场所药物测试市场的最终用途变化分析
  • 2018-2030 年美国雇主和工作场所药物检测市场规模和趋势分析（按最终用途）
  • 资讯科技/金融
  • 製造业
  • 运输
  • 建造
  • 零售和酒店业
  • 卫生保健
  • 教育
  • 其他专业服务

第9章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 主要身份验证提供者/方案所有者列表
  • 公司简介/上市公司
    • First Advantage
    • Laboratory Corporation of America Holdings（Labcorp）
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Clinical Reference Laboratory Inc.
    • Quest Diagnostics
    • Cordant Health Solutions
    • DISA Global Solutions
    • HireRight, LLC
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories
Product Code: GVR-4-68040-450-9

U.S. Employer And Workplace Drug Testing Market Growth & Trends:

The U.S. employer and workplace drug testing market size is anticipated to reach USD 3.47 billion by 2030, growing at a CAGR 5.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Regulatory compliance is a significant driver for market growth. Federal regulations, such as those from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA), mandate testing for safety-sensitive roles to ensure workplace safety and mitigate liability risks. These regulations enforce testing across industries, especially those involving heavy machinery or transportation.

In 2020, the American Public Health Association further emphasized the importance of drug testing by advocating for comprehensive strategies to address Opioid Use Disorder (OUD) and overdose risks in occupational settings. Their recommendations included strengthening injury prevention programs, addressing ergonomic risks, providing opioid misuse education, offering peer support, and regulating opioid prescriptions through workers' compensation. This policy push underscores the growing need for proactive drug testing measures.

In response to these regulatory and policy pressures, the U.S. DOT finalized new regulations in May 2023, allowing oral fluid testing for DOT-mandated drug tests, provided that at least two SAMHSA-certified laboratories are involved. This development highlights the evolving landscape of drug testing, enhancing the flexibility and accuracy of testing programs. By broadening testing options, the new regulation is expected to drive demand for oral fluid testing solutions, benefiting both employers and testing providers and supporting the overall market growth.

Additionally, the increase in substance use disorders (SUDs) among the workforce significantly impacts the growth of the U.S. employer & workplace drug testing market. The prevalence of these disorders contributes to higher rates of absenteeism, lower productivity, and increased workplace accidents. Employers are therefore compelled to implement rigorous drug testing programs to identify and address substance abuse issues promptly. This proactive approach not only helps in maintaining a safe and productive work environment but also reduces operational risks and legal liabilities associated with impaired employees. The growing recognition of the adverse effects of SUDs drives demand for more advanced and comprehensive drug testing solutions, contributing to the market's expansion.

Furthermore, as organizations prioritize creating safer work environments, drug testing becomes an essential component of their safety programs. The awareness of the risks associated with substance abuse, including impaired judgment and increased accident rates, motivates employers to implement robust policies. This focus on safety is particularly pronounced in high-risk industries such as construction, manufacturing, and transportation. By identifying and addressing substance abuse issues, employers can mitigate potential hazards, improve overall workplace safety, and reduce associated costs. The increased awareness and commitment to safety drive the demand for comprehensive solutions, fueling market growth.

U.S. Employer And Workplace Drug Testing Market Report Highlights:

  • Based on type, the post-employment segment dominated the market with a revenue share of 80.80% in 2023. Reducing the risk of accidents, workplace injuries, and associated liabilities is a crucial driver for post-employment drug testing in the U.S. Employers in high-risk industries such as construction, transportation, and manufacturing are acutely aware of the dangers posed by impaired employees to workplace safety.
  • Based on product, the consumable segment dominated the market with a revenue share of 33.42% in 2023. This segment is vital for ensuring the accuracy and reliability of drug tests, which directly impacts the effectiveness of drug screening programs. The regulatory landscape significantly influences the consumables segment, with federal guidelines from the Department of Transportation (DOT) and the Substance Abuse and Mental Health Services Administration (SAMHSA) setting specific standards for drug testing procedures and associated products.
  • Based on mode, the urine segment held the largest market share of 41.38% in 2023. Urine tests are the most common type of pre-employment drug tests used by employers, driven by their established reliability and ease of use. This method remains a staple in both regulated and non-regulated industries, ensuring consistent application across various sectors.
  • Based on drug, the cannabis/marijuana segment held the largest market share of 56.89% in 2023 and is expected to grow at the fastest CAGR over the forecast period. The legalization and decriminalization of marijuana in many states has diminished the stigma surrounding its use, leading to increased consumption, including among employees.
  • Based on end-use, the other professional services segment dominated the market with the largest revenue share of 39.11% in 2023. The demand for employer and workplace drug testing in the U.S. is driven across various professional services sectors, including Professional, Scientific and Technical, Wholesale Trade, and Public Administration industries, due to the critical nature of their work and the need for maintaining high standards of safety, compliance, and productivity.
  • The competitive scenario in the pediatric cardiac tumor diagnostic market is high. The major companies are undertaking various strategies such as new product development, collaborations, acquisitions, and mergers for serving the unmet needs of their customers.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Product Segment
    • 1.2.3. Mode Segment
    • 1.2.4. Drug Segment
    • 1.2.5. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Employer and Workplace Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Employer and Workplace Drug Testing Market Type Movement Analysis
  • 4.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Pre-employment Drug Screens
    • 4.4.1. Pre-employment drug screens market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Post-employment
    • 4.5.1. Post-employment market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Employer and Workplace Drug Testing Market Product Movement Analysis
  • 5.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Rapid Testing Devices
    • 5.6.1. Rapid testing devices market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Services
    • 5.7.1. Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Employer and Workplace Drug Testing Market Mode Movement Analysis
  • 6.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Hair
    • 6.5.1. Hair market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Oral Fluid
    • 6.6.1. Oral fluid market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Instant testing
    • 6.7.1. Instant testing market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Employer and Workplace Drug Testing Market Drug Movement Analysis
  • 7.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Drug, 2018 to 2030 (USD Million)
  • 7.4. Alcohol
    • 7.4.1. Alcohol market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Cannabis/Marijuana
    • 7.5.1. Cannabis/marijuana market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Cocaine
    • 7.6.1. Cocaine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Opioids
    • 7.7.1. Opioids testing market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Amphetamine & Methamphetamine
    • 7.8.1. Amphetamine & methamphetamine market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. LSD
    • 7.9.1. LSD market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.10. Others
    • 7.10.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Employer and Workplace Drug Testing Market End Use Movement Analysis
  • 8.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 8.4. IT/Finance
    • 8.4.1. IT/finance market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Manufacturing
    • 8.5.1. Manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Transportation
    • 8.6.1. Transportation market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. Construction
    • 8.7.1. Construction market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.8. Retail and Hospitality
    • 8.8.1. Retail and hospitality market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.9. Healthcare
    • 8.9.1. Healthcare market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.10. Education
    • 8.10.1. Education surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.11. Other Professional Services
    • 8.11.1. Other Professional Services market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. List of Key Certification Providers/Scheme Owners
  • 9.5. Company Profiles/Listing
    • 9.5.1. First Advantage
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Laboratory Corporation of America Holdings (Labcorp)
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Dragerwerk AG & Co. KGaA
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Bio-Rad Laboratories, Inc.
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Abbott
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Clinical Reference Laboratory Inc.
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Quest Diagnostics
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Cordant Health Solutions
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. DISA Global Solutions
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HireRight, LLC
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. OraSure Technologies, Inc.
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Psychemedics Corporation
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Omega Laboratories
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. employer and workplace drug testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 U.S. employer and workplace drug testing market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. employer and workplace drug testing market, by mode, 2018 - 2030 (USD Million)
  • Table 5 U.S. employer and workplace drug testing market, by drug, 2018 - 2030 (USD Million)
  • Table 6 U.S. employer and workplace drug testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. employer and workplace drug testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. employer and workplace drug testing market: Type outlook key takeaways
  • Fig. 20 U.S. employer and workplace drug testing market: Type movement analysis
  • Fig. 21 Pre-employment drug screens market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Post-employment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. employer and workplace drug testing market: Product outlook key takeaways
  • Fig. 24 U.S. employer and workplace drug testing market: Product movement analysis
  • Fig. 25 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Rapid testing devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 30 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 31 Urine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Hair market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Oral fluid market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Instant testing estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 36 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 37 Alcohol market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Cannabis/marijuana market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cocaine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Opioids estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 LSD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. employer and workplace drug testing market: End use outlook key takeaways
  • Fig. 45 U.S. employer and workplace drug testing market: End use movement analysis
  • Fig. 46 IT/finance market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Transportation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Construction estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Retail and hospitality market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Healthcare market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Education market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Other professional services market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Market participant categorization
  • Fig. 55 U.S. employer and workplace drug testing market position analysis, 2023
  • Fig. 56 Strategic framework